Dapagliflozin and 54-week kidney function in kidney transplant recipients with post-transplant diabetes mellitus: a randomized controlled trial. // Diabetes Research and Clinical Practice. – URL: https://www.sciencedirect.com/science/article/pii/S0168822726005255?dgcid=rss_sd_all
Dapagliflozin and 54-week kidney function in kidney transplant recipients with post-transplant diabetes mellitus: a randomized controlled trial. Diabetes Research and Clinical Practice. https://www.sciencedirect.com/science/article/pii/S0168822726005255?dgcid=rss_sd_all
“Dapagliflozin and 54-week kidney function in kidney transplant recipients with post-transplant diabetes mellitus: a randomized controlled trial.” Diabetes Research and Clinical Practice.
@article{article88964,
title = {Dapagliflozin and 54-week kidney function in kidney transplant recipients with post-transplant diabetes mellitus: a randomized controlled trial},
journal = {Diabetes Research and Clinical Practice},
url = {https://www.sciencedirect.com/science/article/pii/S0168822726005255?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...